Prognostic factors for hepatitis B acute-on-chronic liver failure
-
摘要:
目的探讨影响乙型肝炎相关慢加急性肝衰竭患者预后的危险因素。方法记录263例乙型肝炎相关慢加急性肝衰竭患者治疗基线时血清胆碱酯酶、白蛋白及胆固醇等反应肝脏储备功能的临床指标及重要并发症的发生情况,并计算其MELD评分。所有患者随访满1年。通过Cox比例风险回归模型筛选出影响预后的独立危险因素。结果在1年的随访时间内,67例死亡,病死率为25.5%。死亡组血清胆碱酯酶、白蛋白、胆固醇水平均较存活组低。血清胆固醇水平随着MELD值的升高而下降。Cox比例风险回归模型分析得出,肝性脑病、肝肾综合征、上消化道出血、胆固醇≤2.5 mmol/L、MELD评分≥30是影响乙型肝炎相关慢加急性肝衰竭患者预后的独立危险因素,RR分别为6.286、2.983、2.272、2.168及1.853。结论胆固醇≤2.5 mmol/L、肝性脑病、肝肾综合征、上消化道出血及MELD评分≥30是决定乙型肝炎相关慢加急性肝衰竭患者预后的主要危险因素。
Abstract:Objective To investigate the prognostic value of risk factors in hepatitis B patients with acute-on-chronic liver failure (ACLF) .Methods A total of 263 patients with hepatitis B-ACLF were enrolled in the study.The baseline levels of albumin (Alb) , cholinesterase (CHE) , and total cholesterol (TC) were measured, any complications were recorded, and the MELD score was calculated.All of the patients were followed-up for one year.The prognostic value of known risk factors was analyzed by the multivariate Cox proportional hazard model.Results Sixty-seven patients died within the 1-year follow-up period, yielding a mortality rate of 25.5%.The baseline levels of Alb, CHE, and TC were all significantly lower in the patients who ultimately died than in those who survived.The serum TC level was found to be inversely correlated with increases in the MELD score.Hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, TC≤2.5 mmol/L, and MELD score≥30 were identified as independent prognostic factors for hepatitis B-ACLF.Conclusion Several risk factors of hepatitis B-ACLF are prognostic factors of disease outcome, namely death within one year, including hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, TC≤2.5 mmol/L, and MELD≥30.
-
Key words:
- hepatitis B virus /
- liver failure /
- risk factors /
- prognosis
-
[1]中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志, 2006, 14 (9) :643-646. [2]周锐, 甘巧蓉, 郑彩霞, 等.乙型肝炎慢加急性肝功能衰竭患者人工肝治疗的生存分析及其影响因素[J].肝脏, 2011, 16 (4) :286-290. [3]Malinchoc M, Kamath PS, Gordon FD, et al.A model topredict poor survival in patients undergoing transjugular intra-hepatic portosyBtemic shunts[J].Hepatology, 2000, 31 (4) :864-871. [4]陈学兵, 朱霞, 唐红.终末期肝病3种评分体系对急性肝衰竭患者预后的评估[J].世界华人消化杂志, 2011, 19 (8) :855-859. [5] 高国生, 朱海超.终末期肝病模型 (MELD) 、MELD—Na及iMELD评分系统对乙型肝炎慢加急性肝衰竭患者短期预后的评价[J].中华内科杂志, 2010, 49 (12) :1057-1059. [6]丁淑芬, 徐立新, 蔡晓娟.MELD对慢加亚急性肝衰竭预后的判断价值[J].肝脏, 2011, 16 (6) :506-507. [7]董飞波, 周健.MELD与iMELD对乙型肝炎慢加急性肝衰竭患者短期预后的评价[J].现代实用医学, 2010, 22 (1) :34-35. [8]洪亮, 叶志勇, 孙庆丰, 等.慢加急性乙型肝炎肝衰竭并发症与预后的关系研究[J].中国微生态学杂志, 2011, 23 (9) :829-831. [9]汤伟亮, 赵钢德, 董志霞, 等.肝衰竭预后危险因素及预后模型建立的研究[J].传染病信息, 2011, 24 (3) :159-162. [10]汤伟亮, 赵钢德, 董志霞, 等.乙型肝炎相关肝功能衰竭患者预后危险因素及预后模型建立[J].肝脏, 2011, 16 (5) :367-369. [11]赖宁, 郭树华, 张大志, 等.重型肝炎预后单因素分析与评估系统研究[J].中华肝脏病杂志, 2005, 8 (13) :586-589. [12]李保森, 邹正升, 陈菊梅, 等.慢性重型肝炎并发症与预后的关系[J].中国医师杂志, 2002, 4 (10) :1097.
计量
- 文章访问数: 3099
- HTML全文浏览量: 21
- PDF下载量: 712
- 被引次数: 0